SCHEMBL25538338

SCHEMBL25538338

CC1(C)c2ccc(-c3ccc(-c4cc(-c5ccc6ccccc6c5)nc(-c5cccc6ccccc56)n4)c4ccccc34)cc2-c2cc3ccccc3cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.41
CYP1A2 P05177 2/20 0.36
CTRC Q99895 1/20 0.35
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
ENPP3 O14638 1/20 0.34
ENPP1 P22413 1/20 0.34
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
CYP2B6 P20813 1/20 0.33
CYP2C19 P33261 1/20 0.33
SLC6A2 P23975 2/20 0.32
SLC6A4 P31645 2/20 0.32
SLC6A3 Q01959 2/20 0.32
CHRNA1 P02708 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25538215 0.96 PIM1 (0.42) PIM1CYP1A2CTRCCYP1A1CYP1B1
SCHEMBL25533778 0.95 PIM1 (0.42) PIM1CYP1A2CTRCCYP1A1CYP1B1
SCHEMBL25534006 0.95 PIM1 (0.42) PIM1CYP1A2CTRCCYP1A1CYP1B1
SCHEMBL25540446 0.94 ENPP3 (0.37) PIM1ENPP3ENPP1S1PR1S1PR3
SCHEMBL25538341 0.94 ENPP3 (0.37) PIM1ENPP3ENPP1S1PR1S1PR3
SCHEMBL25539326 0.93 ENPP3 (0.37) PIM1CYP1A1CYP1B1ENPP3ENPP1
SCHEMBL25538334 0.93 ENPP3 (0.37) PIM1CYP1A1CYP1B1ENPP3ENPP1
SCHEMBL25533719 0.92 PIM1 (0.43) PIM1CYP1A2CTRCCYP1A1CYP1B1
SCHEMBL25533495 0.92 PIM1 (0.43) PIM1CYP1A2CTRCCYP1A1CYP1B1
SCHEMBL25533918 0.92 PIM1 (0.40) PIM1CYP1A2CTRCCYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM PIM1 1763/4885CYP1A2 1590/4885CTRC 3942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.